Aegis CEO Basile – ‘Medication adherence is our core product offering, competency’ – NashvillePost Written by: Alex Curtis | Posted Jul 16, 2018 via ‘Medication adherence is our core product offering, competency’ | Nashville Post Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window) Related Tags: Aegis Sciences Corporation health data healthcare healthtech medication NashvillePost Further Reading: Xsolis Announces Its Return as Platinum Sponsor of the American Case Management Association (ACMA) National Conference for the 7th Consecutive Year Written by: Alex Curtis | Posted Mar 26, 2025 Read More › S3 Acquires ERS Assets Written by: Alex Curtis | Posted Mar 25, 2025 Read More › EvidenceCare Acquires Agathos to Advance Physician Enablement and Reduce Clinical Variation Written by: Alex Curtis | Posted Mar 12, 2025 Read More ›